Cecilia Graziosi received her Ph.D. degree in biological sciences from the University of Rome La Sapienza, Italy, in 1984, and her executive M.B.A. degree in management of technology under the joined sponsorship of EPFL and HEC-UNIL in Lausanne, Switzerland, in 2007. In 1987, she joined the Laboratory of Evolutionary Biology, Yale University, New Haven, Conn, USA, to perform postdoctoral studies in tropical diseases. In 1988, she joined Malaria Section at the NIAID, NIH, Bethesda, Md, USA, where she was the first to map genes on polytene chromosomes of adult malaria mosquitoes by in situ hybridization. From 1990 to 1996, she was appointed as a Visiting Scientist at the AIDS Immunopathogenesis Section of the Laboratory of Immunoregulation, NIAID, NIH, Bethesda, Md, USA. In 1996, she moved to the Laboratory of AIDS Immunopathogenesis, Division of Immunology and Allergy, CHUV, Lausanne, Switzerland, where she serves as the Chief of the HIV Variability unit. Her major research interests reside in the pathogenetic mechanisms of HIV infection and particularly in the genesis of intrapatient length polymorphism observed in hypervariable regions of HIV-1 gp120. Her role to the understanding of the immunopathogenetic mechanisms of HIV disease is well documented by the number of contributions she has made in the high-quality refereed journals.
Biography Updated on 10 November 2011